A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma
Clinical trial NCT01412307 · UNKNOWN
Trial details
- NCT number
- NCT01412307
- Sponsor
- Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2015-07-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.